EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
(Dollars and shares in millions except per- | ||||||||||||||||
share data) | ||||||||||||||||
BASIC | ||||||||||||||||
Net income | $ | 926.3 | $ | 873.6 | $ | 2,098.6 | $ | 2,530.4 | ||||||||
Average number of common shares outstanding | 1,089.1 | 1,085.2 | 1,088.8 | 1,085.0 | ||||||||||||
Contingently issuable shares | 1.0 | .4 | 1.0 | .4 | ||||||||||||
Adjusted average shares | 1,090.1 | 1,085.6 | 1,089.8 | 1,085.4 | ||||||||||||
Basic earnings per share | $ | .85 | $ | .80 | $ | 1.93 | $ | 2.33 | ||||||||
DILUTED | ||||||||||||||||
Net income | $ | 926.3 | $ | 873.6 | $ | 2,098.6 | $ | 2,530.4 | ||||||||
Average number of common shares outstanding | 1,089.1 | 1,085.2 | 1,088.8 | 1,085.0 | ||||||||||||
Incremental shares — stock options and contingently issuable shares | 1.1 | 1.2 | 1.3 | 1.4 | ||||||||||||
Adjusted average shares | 1,090.2 | 1,086.4 | 1,090.1 | 1,086.4 | ||||||||||||
Diluted earnings per share | $ | .85 | $ | .80 | $ | 1.93 | $ | 2.33 | ||||||||